GE Healthcare works with Applied Biosystems

GE Healthcare announced today that it has completed a license agreement with Applied Biosystems, granting Applied Biosystems access to GE Healthcare patents for the biomagnetic isolation of nucleic acids

The license, which is valid for the lifetime of the patents, grants Applied Biosystems certain rights with respect to the isolation and purification of nucleic acids using GE Healthcare's proprietary magnetic separation technology.

GE Healthcare's patented methods for magnetic separation offer significant advantages over conventional techniques for the isolation and purification of biomolecules such as DNA and RNA from laboratory and clinical samples. Benefits include greater yields of product and elimination of clogging associated with filter-based methods

"This license recognizes the considerable value that our biomagnetic isolation technology brings to genomics researchers" said Eric Roman, General Manager, Genomic Sciences, GE Healthcare. "We are pleased to grant Applied Biosystems access to our patents in this area, which will allow them to use our proprietary magnetic separation protocols in conjunction with their MagMaxTM range of products for nucleic acid isolation"

GE Healthcare has an active program to grant licenses for access to its patents for biomagnetic isolation. Financial terms were not disclosed - General Electric.